Allarity Therapeutics (ALLR) Total Current Liabilities (2020 - 2026)
Allarity Therapeutics' (ALLR) quarterly Total Current Liabilities came in at $28.0 million in Q1 2026, up 153.17% YoY from $11.1 million in Q1 2025, and up 232.18% on a QoQ basis from $8.4 million in Q4 2025.
Allarity Therapeutics (ALLR) Total Current Liabilities (2020 - 2026) Analysis & Trends
Allarity Therapeutics (ALLR) has 7 years of Total Current Liabilities data on file, last reported at $28.0 million in Q1 2026.
- Quarterly Total Current Liabilities rose 153.17% year-over-year to $28.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $28.0 million (up 153.17% YoY) and the FY2025 annual result came in at $8.4 million, down 22.23% from the prior year.
- Total Current Liabilities grew to $28.0 million in Q1 2026, from $8.4 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $28.0 million in Q1 2026 to a low of $7.4 million in Q3 2024.
- A 5-year average of $12.6 million and a median of $11.5 million in 2022 frame the typical range for Total Current Liabilities.
- Annual changes were most pronounced in 2022 — Total Current Liabilities soared 237.55% — and 2024, when it tumbled 52.91%.
- Tracing ALLR's Total Current Liabilities over 5 years: stood at $11.2 million in 2022, then rose by 26.24% to $14.2 million in 2023, then slipped by 23.49% to $10.8 million in 2024, then fell by 22.23% to $8.4 million in 2025, then soared by 232.18% to $28.0 million in 2026.
- The last three Total Current Liabilities figures came in at $28.0 million (Q1 2026), $8.4 million (Q4 2025), and $8.8 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.58 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 2.53 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 2.12 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.51 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 438.74 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 630.93 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 2.49 Bn |
| 10 | Allarity Therapeutics | 23.23 Mn | 23.23 Mn | - | 28.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 28.00 Mn |
| Dec 31, 2025 | 8.43 Mn |
| Sep 30, 2025 | 8.79 Mn |
| Jun 30, 2025 | 9.04 Mn |
| Mar 31, 2025 | 11.06 Mn |
| Dec 31, 2024 | 10.84 Mn |
| Sep 30, 2024 | 7.41 Mn |
| Jun 30, 2024 | 10.62 Mn |
| Mar 31, 2024 | 18.01 Mn |
| Dec 31, 2023 | 14.17 Mn |
| Sep 30, 2023 | 15.74 Mn |
| Jun 30, 2023 | 12.67 Mn |
| Mar 31, 2023 | 11.59 Mn |
| Dec 31, 2022 | 11.22 Mn |
| Sep 30, 2022 | 12.96 Mn |
| Jun 30, 2022 | 11.46 Mn |
| Mar 31, 2022 | 12.71 Mn |
| Dec 31, 2021 | 20.72 Mn |
| Sep 30, 2021 | 3.84 Mn |
| Jun 30, 2021 | 4.34 Mn |